Question 1

What does Biohaven Pharmaceutical do?

Accepted Answer

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Question 2

In what sectors does Biohaven Pharmaceutical operate?

Accepted Answer

Biohaven Pharmaceutical operates in Biotechnology, Health Care, Health Diagnostics, Neuroscience, Pharmaceutical.

Question 3

How many companies has Biohaven Pharmaceutical acquired?

Accepted Answer

Biohaven Pharmaceutical has made 2 acquisitions between 2021-2022, with a total disclosed deal value of $120.0M.

Question 4

What companies are owned by Biohaven Pharmaceutical?

Accepted Answer

Companies acquired by Biohaven Pharmaceutical include Channel Biosciences, Kleo.

Question 5

What are Biohaven Pharmaceutical's major acquisitions?

Accepted Answer

Biohaven Pharmaceutical's largest acquisitions include Channel Biosciences ($100.0M, 2022), Kleo ($20.0M, 2021).

Question 6

What is Biohaven Pharmaceutical's largest acquisition?

Accepted Answer

Biohaven Pharmaceutical's largest disclosed acquisition is Channel Biosciences for $100.0M (2022).

Question 7

What was Biohaven Pharmaceutical's first acquisition?

Accepted Answer

Biohaven Pharmaceutical's first recorded acquisition was Kleo in 2021 for $20.0M.

Question 8

What was Biohaven Pharmaceutical's most recent acquisition?

Accepted Answer

Biohaven Pharmaceutical's most recent acquisition is Channel Biosciences, announced February 2022 for $100.0M.

Question 9

What is the average deal size for Biohaven Pharmaceutical acquisitions?

Accepted Answer

The average disclosed deal size for Biohaven Pharmaceutical acquisitions is $60.0M.

Question 10

What is the median deal size for Biohaven Pharmaceutical acquisitions?

Accepted Answer

The median disclosed deal size for Biohaven Pharmaceutical acquisitions is $60.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Biohaven Pharmaceutical spent on acquisitions?

Accepted Answer

Biohaven Pharmaceutical has spent at least $120.0M across its disclosed acquisitions (of 2 total deals; some prices are undisclosed).

Question 12

Which sector has Biohaven Pharmaceutical spent the most on?

Accepted Answer

Biohaven Pharmaceutical has committed the most disclosed capital to Pharmaceutical companies — about $120.0M across its deals in that sector.

Question 13

What sectors does Biohaven Pharmaceutical usually acquire in?

Accepted Answer

Biohaven Pharmaceutical most frequently acquires companies in Pharmaceutical, Biopharma, Biotechnology.

Question 14

In which sector has Biohaven Pharmaceutical made the most acquisitions?

Accepted Answer

Biohaven Pharmaceutical has made the most acquisitions in the Pharmaceutical sector.

Question 15

In which year did Biohaven Pharmaceutical make the most acquisitions?

Accepted Answer

Biohaven Pharmaceutical made the most acquisitions in 2022, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Biohaven Pharmaceutical

Company Details

Funding & Financials

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Biohaven Pharmaceutical

Acquisitions by Biohaven Pharmaceutical

Key People at Biohaven Pharmaceutical

Explore 200,000+ acquisitions — free

Recent News related to Biohaven Pharmaceutical

FAQs about Biohaven Pharmaceutical

People who checked this page also checked these